Kinney, Brendan L. C.
Gunti, Sreenivasulu
Kansal, Vikash
Parrish, Connor J.
Saba, Nabil F.
Teng, Yong
Henry, Mary Katherine
Su, Fang-Yi
Kwong, Gabriel A.
Schmitt, Nicole C.
Funding for this research was provided by:
Winship Cancer Institute
National Institute on Deafness and Other Communication Disorders (ZIADC-DC000090)
National Institute on Deafness and Other Communication Disorders (ZIADC-DC000090)
National Institute on Deafness and Other Communication Disorders (ZIADC-DC000090)
National Cancer Institute, United States (P30CA138292)
Article History
Received: 28 October 2023
Accepted: 13 December 2023
First Online: 17 January 2024
Declarations
:
: NCS declares consulting for Sensorion, Checkpoint Surgical, Synergy Research, Inc., and Regeneron; and research funding from Astex Pharmaceuticals, Inc. (unrelated to this work).
: Schmitt – <i>Consulting:</i> Checkpoint Surgical, Sensorion, Synergy Research, Regeneron. <i>Book Royalties:</i> Plural Publishing. <i>Clinical Trial Funding:</i> Astex Pharmaceuticals